What 4 Analyst Ratings Have To Say About Phibro Animal Health
Portfolio Pulse from Benzinga Insights
In the last quarter, Phibro Animal Health (NASDAQ:PAHC) received 2 bullish and 2 indifferent ratings from analysts. The company's average 12-month price target is $18.75, which has increased by 7.14% over the past month.

November 09, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phibro Animal Health received mixed ratings from analysts, with an average 12-month price target of $18.75, indicating potential upside.
The company received 2 bullish and 2 indifferent ratings from analysts, indicating a mixed outlook. However, the average 12-month price target of $18.75, which has increased by 7.14% over the past month, suggests potential upside for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100